At the heart of pharmaceutical innovation lies DASHA’s comprehensive CDMO capabilities, specialised in small molecule development and API manufacturing. Our state-of-the-art facilities combine cutting-edge technology with decades of expertise to deliver exceptional results across the entire development spectrum.

Our small molecule capabilities encompass the complete development journey. From initial process development through pilot batches to commercial manufacturing, we provide seamless integration of services. Our advanced analytical capabilities ensure precise characterisation and optimal process control, while our scalable manufacturing solutions adapt to evolving project needs. Our development approach integrates Quality by Design (QbD) principles from the outset. This systematic methodology development minimises risk, optimises processes, and ensures robust manufacturing outcomes. Our regulatory expertise ensures compliance with global standards, supporting smooth submission processes and market approval.

Sustainability and efficiency drive our operations. Through green chemistry initiatives and innovative process solutions, we minimise environmental impact while maintaining superior quality. Our integrated project management ensures transparent communication and timely delivery at every development stage.